Nifurtoinol

This classification denotes a urinary anti-infective agent with the molecular formula C9H8N4O6, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier (SRS UNII) 980688H13O, chemically known as 2,4-imidazolidinedione, 3-(hydroxymethyl)-1-(((5-nitro-2-furanyl)methylene)amino)- but more generally known as nifurtoinol, which bears US NIH Compound Identifier 9571062. European Medicines Agency schedules Nifurtoinol in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09281MIG. The term NIFURTOINOL is an International Non-Proprietary Name or INN (see World Health Organization INN reference publication, Volume 31, No10, 1977, List 17). World Health Organization schedules nifurtoinol in its Anatomical Therapeutic Chemical (ATC) Classification. NIFURTOINOL is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations, for tariff and trade purposes, schedule nifurtoinol under HS 29349990 and SITC 51579. As of Q4 2014, NIFURTOINOL remains US FDA's Preferred Term for this commodity. Nifurtoinol bears US NLM identifiers UMLS ID C0077875 and NCI Concept Code C90997. SMILES: O=C1N(C(=O)N(/N=C/C2OC([N](=O)O)CC2)C1)CO.